Fleseriu, M., Samson, S. L., Nachtigall, L. B., Labadzhyan, A., Elenkova, A., Ludlam, W. H., . . . Melmed, S. (2020). MON-LB55 Biochemical Control of Most Patients Reverting to Injectable Long-Acting Somatostatin Receptor Ligands Is Achieved After One Dose: Results From the Phase 3, Randomized, Double Blind, Placebo-Controlled Optimal Study. J Endocr Soc.
Citação norma ChicagoFleseriu, Maria, et al. "MON-LB55 Biochemical Control of Most Patients Reverting to Injectable Long-Acting Somatostatin Receptor Ligands Is Achieved After One Dose: Results From the Phase 3, Randomized, Double Blind, Placebo-Controlled Optimal Study." J Endocr Soc 2020.
Citação norma MLAFleseriu, Maria, et al. "MON-LB55 Biochemical Control of Most Patients Reverting to Injectable Long-Acting Somatostatin Receptor Ligands Is Achieved After One Dose: Results From the Phase 3, Randomized, Double Blind, Placebo-Controlled Optimal Study." J Endocr Soc 2020.